Seastar Medical Hldg Corp (ICU)

$4.92 +0.06 (1.23%)
Market Cap 19.67M
Revenue (ttm) 1.23M
Net Income (ttm) -12.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -987.80%
Debt to Equity Ratio 0.00
Volume 280,400
Avg Vol 95,124
Day's Range N/A - N/A
Shares Out 4.00M
Stochastic %K 81%
Beta -1.05
Analysts Strong Sell
Price Target $10.00

Company Profile

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 427 8100
Address:
3513 Brighton Boulevard, Suite 410, Denver, United States
Tomasini
Tomasini Jul. 4 at 7:48 PM
$ICU could someone explain what the Save issue to me? It isnt well explained by management like everything else thanks
2 · Reply
Unitypal
Unitypal Jul. 4 at 6:09 PM
$ICU Soon Europe. Soon Asia. Soon World. A Sepsis stopper. For the very 1rst time in mankind’s history. A CURE! TAM? How’s 100+ billion US $$$$$!!!!! That’s just for Sepsis with or without AKI!!!!!! Do the math!!!! 5 other FDA granted BDDs!!!!! How many more are yet to be granted? https://share.google/XhXusB4z3VAnVTnGi
1 · Reply
littleguyfinance
littleguyfinance Jul. 4 at 4:10 PM
$ICU Happy 4th! Can anyone confirm when the new reimbursement codes will take effect? The news release says 10/1/2026 however the investor presentation says 10/1/2027. Is there a typo in the presentation? Frustrating.
2 · Reply
Unitypal
Unitypal Jul. 4 at 1:35 PM
$ICU July 10. ••••• Birthday Fireworks one week later. KaKaKa-Boom!
0 · Reply
newTrader9999
newTrader9999 Jul. 4 at 5:29 AM
$HUMA may be its a good idea for them to reverse split , lower the share count and then run up. RS is not always bad as can be seen for the buyout of the flu drug company from san diego and hopefully soon for $ICU
2 · Reply
local42r
local42r Jul. 4 at 2:54 AM
$ICU Tick tick Tick boom !
0 · Reply
Yi_YandH
Yi_YandH Jul. 3 at 6:17 PM
$ICU
1 · Reply
CanadianDreamcast
CanadianDreamcast Jul. 3 at 4:17 PM
$ICU God bless America
0 · Reply
CanadianDreamcast
CanadianDreamcast Jul. 3 at 4:16 PM
$ICU I'm not a fake I'm just a highly emotional fuck up when I'm not taking care of body mind spirit. Probably related to excess inflammation and cytokines in the brain.....not even joking. Go Bless America
0 · Reply
BULLISH1975
BULLISH1975 Jul. 3 at 1:57 PM
$ICU SP has sucked- yes micro caps can be tough- difficult to time!!! insiders gave sold zero share ever!!! Seastar has made huge progress- insiders got their incentives- they ready for this massive rerate from 18 million MC to hundreds of million in the next 12 months! dyor
0 · Reply
Latest News on ICU
SeaStar Medical Holding Transcript: Investor Summit Virtual Conference

Jun 24, 2026, 10:30 AM EDT - 10 days ago

SeaStar Medical Holding Transcript: Investor Summit Virtual Conference

SeaStar Medical announces new CD-10-PCS codes for SCD therapy

2026-06-23T16:34:58.000Z - 11 days ago

SeaStar Medical announces new CD-10-PCS codes for SCD therapy

SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury

Jun 23, 2026, 8:25 AM EDT - 11 days ago

SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury

SeaStar Medical to Present at Upcoming Investor Summit Conference

Jun 22, 2026, 8:45 AM EDT - 12 days ago

SeaStar Medical to Present at Upcoming Investor Summit Conference

SeaStar Medical price target raised to $8 from $6 at Maxim

2026-05-14T14:34:45.000Z - 7 weeks ago

SeaStar Medical price target raised to $8 from $6 at Maxim

SeaStar Medical Holding Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

SeaStar Medical Holding Earnings Call Transcript: Q1 2026

SeaStar Medical Holding Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

SeaStar Medical Holding Earnings release: Q1 2026

SeaStar Medical Holding Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

SeaStar Medical Holding Quarterly report: Q1 2026

SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates

May 13, 2026, 4:05 PM EDT - 7 weeks ago

SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates

SeaStar Medical Holding Registration statement: Registration filing

May 7, 2026, 8:00 AM EDT - 2 months ago

SeaStar Medical Holding Registration statement: Registration filing

SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

May 6, 2026, 8:20 AM EDT - 2 months ago

SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

SeaStar Medical Holding Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

SeaStar Medical Holding Proxy statement: Proxy filing

SeaStar Medical Holding Registration statement: Registration filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

SeaStar Medical Holding Registration statement: Registration filing

SeaStar Medical showcases new data from SAVE Registry

2026-03-30T13:27:26.000Z - 3 months ago

SeaStar Medical showcases new data from SAVE Registry

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

Mar 30, 2026, 8:20 AM EDT - 3 months ago

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

SeaStar Medical Holding Earnings Call Transcript: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 3 months ago

SeaStar Medical Holding Earnings Call Transcript: Q4 2025

SeaStar Medical Holding Annual report: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 3 months ago

SeaStar Medical Holding Annual report: Q4 2025

SeaStar Medical Holding Earnings release: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 3 months ago

SeaStar Medical Holding Earnings release: Q4 2025

SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Mar 25, 2026, 4:05 PM EDT - 3 months ago

SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

Mar 18, 2026, 4:05 PM EDT - 3 months ago

SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

SeaStar Medical Holding Transcript: Life Sciences Virtual Investor Forum

Mar 11, 2026, 12:00 PM EDT - 4 months ago

SeaStar Medical Holding Transcript: Life Sciences Virtual Investor Forum

SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th

Mar 9, 2026, 8:35 AM EDT - 4 months ago

SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th

SeaStar Medical completes FDA enrollment requirement for SAVE Registry

2026-03-05T13:36:45.000Z - 4 months ago

SeaStar Medical completes FDA enrollment requirement for SAVE Registry

SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

Mar 5, 2026, 8:20 AM EST - 4 months ago

SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

SeaStar Medical price target lowered to $6 from $10 at Maxim

2026-02-12T14:06:17.000Z - 5 months ago

SeaStar Medical price target lowered to $6 from $10 at Maxim

SeaStar Medical reports ‘strong’ survival data in Quelimmune study

2026-02-09T13:25:53.000Z - 5 months ago

SeaStar Medical reports ‘strong’ survival data in Quelimmune study

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

Feb 9, 2026, 8:20 AM EST - 5 months ago

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

Jan 29, 2026, 8:25 AM EST - 5 months ago

SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

SeaStar Medical Holding Transcript: Biotech Showcase 2026

Jan 13, 2026, 6:00 PM EST - 6 months ago

SeaStar Medical Holding Transcript: Biotech Showcase 2026

SeaStar Medical Holding Slides: Investor presentation

Jan 9, 2026, 7:00 AM EST - 6 months ago

SeaStar Medical Holding Slides: Investor presentation

SeaStar Medical announces 2026 milestones

2026-01-07T13:21:08.000Z - 6 months ago

SeaStar Medical announces 2026 milestones

SeaStar Medical Announces 2026 Milestones

Jan 7, 2026, 8:13 AM EST - 6 months ago

SeaStar Medical Announces 2026 Milestones

SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

Jan 6, 2026, 8:53 AM EST - 6 months ago

SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

SeaStar Medical Holding Corp trading halted, news pending

2026-01-03T00:50:17.000Z - 6 months ago

SeaStar Medical Holding Corp trading halted, news pending

SeaStar Medical announces 1-for-10 reverse stock split

2025-12-23T21:30:17.000Z - 6 months ago

SeaStar Medical announces 1-for-10 reverse stock split

SeaStar Medical Announces 1-for-10 Reverse Split

Dec 23, 2025, 4:25 PM EST - 6 months ago

SeaStar Medical Announces 1-for-10 Reverse Split

SeaStar reports approval for reduction in mandatory enrollment for SAVE registry

2025-12-02T13:30:31.000Z - 7 months ago

SeaStar reports approval for reduction in mandatory enrollment for SAVE registry

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

Dec 2, 2025, 8:27 AM EST - 7 months ago

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

Nov 20, 2025, 9:52 AM EST - 8 months ago

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

SeaStar Medical appoints Michael Messinger as CFO

2025-11-17T13:50:19.000Z - 8 months ago

SeaStar Medical appoints Michael Messinger as CFO

SeaStar Medical Announces Appointment of Michael Messinger as CFO

Nov 17, 2025, 8:43 AM EST - 8 months ago

SeaStar Medical Announces Appointment of Michael Messinger as CFO

SeaStar Medical Holding Proxy statement: Proxy Filing

Nov 14, 2025, 7:00 AM EST - 8 months ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

SeaStar Medical Holding Earnings Call Transcript: Q3 2025

SeaStar Medical Holding Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

SeaStar Medical Holding Quarterly report: Q3 2025

SeaStar Medical Holding Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

SeaStar Medical Holding Earnings release: Q3 2025

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 13, 2025, 4:05 PM EST - 8 months ago

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

Nov 5, 2025, 10:03 AM EST - 8 months ago

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

SeaStar Medical Holding Proxy statement: Proxy Filing

Nov 4, 2025, 7:00 AM EST - 8 months ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical announces preliminary results from SAVE Surveillance Registry

2025-09-29T13:00:23.000Z - 9 months ago

SeaStar Medical announces preliminary results from SAVE Surveillance Registry

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Sep 29, 2025, 8:36 AM EDT - 9 months ago

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Why Is SeaStar Medical Stock (ICU) Down 45% Today?

2025-09-25T13:24:14.000Z - 10 months ago

Why Is SeaStar Medical Stock (ICU) Down 45% Today?

Review board recommends SeaStar Medical continue with NEUTRALIZE-AKI trial

2025-09-24T20:40:35.000Z - 10 months ago

Review board recommends SeaStar Medical continue with NEUTRALIZE-AKI trial

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Sep 24, 2025, 4:22 PM EDT - 10 months ago

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

Sep 23, 2025, 8:23 AM EDT - 10 months ago

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

SeaStar Medical Holding Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 5, 2025, 7:00 AM EDT - 10 months ago

SeaStar Medical Holding Transcript: H.C. Wainwright 27th Annual Global Investment Conference

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 6:13 PM EDT - 10 months ago

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

SeaStar Medical announces newly published QUELIMMUNE therapy

2025-09-02T12:45:53.000Z - 10 months ago

SeaStar Medical announces newly published QUELIMMUNE therapy

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

Sep 2, 2025, 8:22 AM EDT - 10 months ago

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

SeaStar Medical Holding Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

SeaStar Medical Holding Earnings Call Transcript: Q2 2025

SeaStar Medical Holding Quarterly report: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

SeaStar Medical Holding Quarterly report: Q2 2025

SeaStar Medical Holding Earnings release: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

SeaStar Medical Holding Earnings release: Q2 2025

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 13, 2025, 4:05 PM EDT - 11 months ago

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical files to sell 10.92M shares of common stock for holders

2025-08-08T21:10:33.000Z - 11 months ago

SeaStar Medical files to sell 10.92M shares of common stock for holders

SeaStar Medical Holding Registration statement: Registration Filing

Aug 8, 2025, 8:00 AM EDT - 11 months ago

SeaStar Medical Holding Registration statement: Registration Filing

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

Aug 7, 2025, 10:00 AM EDT - 11 months ago

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

SeaStar Medical reaches new enrollment milestone in NEUTRALIZE-AKI trial

2025-08-06T12:42:53.000Z - 11 months ago

SeaStar Medical reaches new enrollment milestone in NEUTRALIZE-AKI trial

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

Aug 6, 2025, 8:33 AM EDT - 11 months ago

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

SeaStar Medical announces $4.4M registered direct offering priced at-the-market

2025-07-31T19:10:42.000Z - 1 year ago

SeaStar Medical announces $4.4M registered direct offering priced at-the-market

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 31, 2025, 3:01 PM EDT - 1 year ago

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

Jul 22, 2025, 8:20 AM EDT - 1 year ago

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Jul 16, 2025, 8:45 AM EDT - 1 year ago

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 10, 2025, 3:29 PM EDT - 1 year ago

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

Jul 8, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

SeaStar Medical Announces Positive Nasdaq Listing Determination

Jul 2, 2025, 4:25 PM EDT - 1 year ago

SeaStar Medical Announces Positive Nasdaq Listing Determination

SeaStar Medical Reports Update on Nasdaq Listing Status

Jun 25, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Reports Update on Nasdaq Listing Status

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

Jun 24, 2025, 9:05 AM EDT - 1 year ago

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

Jun 20, 2025, 12:10 PM EDT - 1 year ago

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

SeaStar Medical Holding Registration statement: Registration Filing

Jun 20, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

SeaStar Medical Holding Registration statement: Registration Filing

Jun 16, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

Jun 11, 2025, 8:25 AM EDT - 1 year ago

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

May 28, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

SeaStar Medical Holding Slides: Investor Presentation

May 20, 2025, 7:00 AM EDT - 1 year ago

SeaStar Medical Holding Slides: Investor Presentation

SeaStar Medical Holding Registration statement: Registration Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

SeaStar Medical Holding Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings Call Transcript: Q1 2025

SeaStar Medical Holding Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Quarterly report: Q1 2025

SeaStar Medical Holding Earnings release: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings release: Q1 2025

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

May 14, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

May 13, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

May 7, 2025, 10:00 AM EDT - 1 year ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

SeaStar Medical Holding Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

Apr 30, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

SeaStar Medical Holding Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Registration statement: Registration Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Apr 8, 2025, 8:05 AM EDT - 1 year ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

SeaStar Medical Holding Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings Call Transcript: Q4 2024

SeaStar Medical Holding Annual report: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Annual report: Q4 2024

SeaStar Medical Holding Earnings release: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings release: Q4 2024

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 27, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 24, 2025, 5:30 PM EDT - 1 year ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Mar 18, 2025, 8:45 AM EDT - 1 year ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

SeaStar Medical Holding Proxy statement: Proxy Filing

Mar 4, 2025, 7:00 AM EST - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Proxy statement: Proxy Filing

Feb 28, 2025, 7:00 AM EST - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Proxy statement: Proxy Filing

Feb 18, 2025, 7:00 AM EST - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

Feb 3, 2025, 4:05 PM EST - 1 year ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

Jan 22, 2025, 7:30 AM EST - 1 year ago

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Jan 13, 2025, 8:30 AM EST - 1 year ago

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

SeaStar Medical Holding Slides: Investor Presentation

Jan 13, 2025, 7:00 AM EST - 1 year ago

SeaStar Medical Holding Slides: Investor Presentation

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

Jan 8, 2025, 8:30 AM EST - 1 year ago

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

Tomasini
Tomasini Jul. 4 at 7:48 PM
$ICU could someone explain what the Save issue to me? It isnt well explained by management like everything else thanks
2 · Reply
Unitypal
Unitypal Jul. 4 at 6:09 PM
$ICU Soon Europe. Soon Asia. Soon World. A Sepsis stopper. For the very 1rst time in mankind’s history. A CURE! TAM? How’s 100+ billion US $$$$$!!!!! That’s just for Sepsis with or without AKI!!!!!! Do the math!!!! 5 other FDA granted BDDs!!!!! How many more are yet to be granted? https://share.google/XhXusB4z3VAnVTnGi
1 · Reply
littleguyfinance
littleguyfinance Jul. 4 at 4:10 PM
$ICU Happy 4th! Can anyone confirm when the new reimbursement codes will take effect? The news release says 10/1/2026 however the investor presentation says 10/1/2027. Is there a typo in the presentation? Frustrating.
2 · Reply
Unitypal
Unitypal Jul. 4 at 1:35 PM
$ICU July 10. ••••• Birthday Fireworks one week later. KaKaKa-Boom!
0 · Reply
newTrader9999
newTrader9999 Jul. 4 at 5:29 AM
$HUMA may be its a good idea for them to reverse split , lower the share count and then run up. RS is not always bad as can be seen for the buyout of the flu drug company from san diego and hopefully soon for $ICU
2 · Reply
local42r
local42r Jul. 4 at 2:54 AM
$ICU Tick tick Tick boom !
0 · Reply
Yi_YandH
Yi_YandH Jul. 3 at 6:17 PM
$ICU
1 · Reply
CanadianDreamcast
CanadianDreamcast Jul. 3 at 4:17 PM
$ICU God bless America
0 · Reply
CanadianDreamcast
CanadianDreamcast Jul. 3 at 4:16 PM
$ICU I'm not a fake I'm just a highly emotional fuck up when I'm not taking care of body mind spirit. Probably related to excess inflammation and cytokines in the brain.....not even joking. Go Bless America
0 · Reply
BULLISH1975
BULLISH1975 Jul. 3 at 1:57 PM
$ICU SP has sucked- yes micro caps can be tough- difficult to time!!! insiders gave sold zero share ever!!! Seastar has made huge progress- insiders got their incentives- they ready for this massive rerate from 18 million MC to hundreds of million in the next 12 months! dyor
0 · Reply
OldManLogan
OldManLogan Jul. 3 at 12:30 PM
$ICU Ya, you "saved" anyone that listened to you from a 71% profit in just 3 weeks. Imagine how much you will have saved them by the time the SAVE registry is published over the next month or so... 😬 Have to admire your capacity to remain arrogant even in the face of devastatingly bad calls.
4 · Reply
BULLISH1975
BULLISH1975 Jul. 3 at 12:26 PM
$ICU fake bulls will be gone when SP breaks $15 in a few months!!!! Adult SCD will likely get approved…. more than 20 hospitals will be instant buyers. it will be a new SOC after a few quarters you can expect huge growth if revenue!!! 20 plus hospitals enrolling at about $15K per treatment!!!! Adult revenue will be 10’s of millions a quarter very quickly!!!!! do your research! Have a great weekend.
0 · Reply
Blastus
Blastus Jul. 3 at 12:13 PM
$ICU How much you want to bet all those shares they just gave themselves are about to get sold on the market because they need money/paychecks? They're incahoots with an institution that ran price up so they can feast. Investors to them are nothing more than rags to wipe their mouths with after they wine and dine on your expense. Schlorrf humbly thanks you
1 · Reply
gaizka36
gaizka36 Jul. 3 at 7:52 AM
$ICU guys, can you help pls? Quick update on the timeline? Have been focused on SLS and want to double my stake here, several k of shares.
2 · Reply
CanadianDreamcast
CanadianDreamcast Jul. 3 at 4:41 AM
$ICU this thing still has the ability to give all its gains back for no reason at all besides algorithms mind fucking retail. Let's hope the billionaire class turns their attention to some other nefarious bullshit.
0 · Reply
ACstranger
ACstranger Jul. 3 at 4:30 AM
$ICU thrash
0 · Reply
Yi_YandH
Yi_YandH Jul. 3 at 3:26 AM
$ICU I miss the Europeans on this board.
2 · Reply
MasheredTrader
MasheredTrader Jul. 3 at 1:18 AM
$ICU Do you remember that thought in the back of your mind.. that “someday I’ll own something that explodes in price like some other investors brag of” that you’ll invest huge into something that grows so much that you make millions? Well? this is that ticker that will reassure you that it can and will be you. Buy now and you’ll be one of those millionaires. In 6 months you’ll have great gains.. but wait to 12 months? Your mind will be blown.
1 · Reply
MasheredTrader
MasheredTrader Jul. 3 at 12:10 AM
$ICU the after hours price reflects the usual “Friday” end of day selling. Yesterday’s volume was so great that it had to have some institutional buying involved. Monday we will see continuation of a bullish trend.
0 · Reply
dillydally1
dillydally1 Jul. 2 at 10:06 PM
$ICU just want to say that this is one of the few times when I feel like I’m actually an investor. My money is making a difference to support this company. And I hope to be rewarded for it. I guess I helped ASTS as well with my money but it was a drop in the bucket for them, with ICU your dollars can go a lot further right now
0 · Reply
OldManLogan
OldManLogan Jul. 2 at 10:01 PM
$ICU Any long-term shareholder should ABSOLUTELY want management to be aligned and incentivized to maximize the share price. Literally DECADES of empirical data shows that both productivity and share prices $$$$$$ magically tend to rise after management and employees receive incentive grants. Issuing shares as a part of a compensation plan also helps early commercial companies preserve cash... or perhaps you think management should be doing this out of the goodness of their hearts? lol. As a 0.8% owner of this company, these incentive shares have my full support.
1 · Reply
Yi_YandH
Yi_YandH Jul. 2 at 9:35 PM
$ICU Employees, aka company officers, get rewarded for their hard work. There are only 19 of them so the pain to shareholders is limited and I have always enjoyed company incentives and bonuses. Hopefully, the SeaStar working stiffs get their fair piece of the public company’s pie @ Christmas or Yom Kipper or New Years or something. Shareholders - Hold Shareholders - Add Shareholders - Retire Early Shareholders - Buy 25’-75’ Seaworthy Vessels Shareholders - Leave Their Children ………………………Cold,Hard, Cash!
1 · Reply